Chris Rallis
Director/Board Member bij AEOLUS PHARMACEUTICALS, INC.
Vermogen: 509 719 $ op 31-03-2024
Profiel
Chris A.
Rallis is an Independent Director at Fennec Pharmaceuticals, Inc., Aeolus Pharmaceuticals, Inc., and Salisbury School, Inc. He was previously the President & Chief Executive Officer at ImmunoBiosciences, Inc. and President, Chief Operating Officer & Director at Triangle Pharmaceuticals, Inc. He also served as a Director at Incara Pharmaceuticals Corp.
and as VP-Strategic Planning & Business Development at Burroughs Wellcome.
Rallis holds a graduate degree from Duke University and an undergraduate degree from Harvard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-04-2024 | 45 838 ( 0.17% ) | 509 719 $ | 31-03-2024 |
Actieve functies van Chris Rallis
| Bedrijven | Functie | Begin |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 01-06-2004 |
| FENNEC PHARMACEUTICALS INC. | Director/Board Member | 25-08-2011 |
| Salisbury School, Inc. | Director/Board Member | - |
Eerdere bekende functies van Chris Rallis
| Bedrijven | Functie | Einde |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Director/Board Member | 10-06-2021 |
ImmunoBiosciences, Inc.
 ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | 01-06-2007 |
| Incara Pharmaceuticals Corp. | Director/Board Member | 09-08-2004 |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | President | 01-01-2003 |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | - |
Opleiding van Chris Rallis
| Duke University | Graduate Degree |
| Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| FENNEC PHARMACEUTICALS INC. | Health Technology |
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
| Incara Pharmaceuticals Corp. | Health Technology |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Technology Services |
| Burroughs Wellcome | |
| Salisbury School, Inc. |
